650 East Kendall Street, Cambridge, MA 02142
Aging Code Summit | 650 E Kendall St
ACS 2026 returns to Cambridge, bringing together top minds to discuss basic scientific, translational, and financial advancements in aging.
Aging research is entering a new phase.
For years, the field has been driven by foundational discoveries across epigenetics, immune aging, mitochondrial biology, and neurodegeneration. Today, those insights are beginning to move beyond the lab and into therapeutics, diagnostics, and real clinical strategies.
At the same time, advances in biomarker development, longitudinal data collection, and AI-driven analysis are reshaping how aging is measured, tracked, and ultimately intervened on.
Aging Code Summit is designed around this shift.
Now in its second year and becoming one of Longevity Global’s flagship events, the summit brings together a highly curated group of ~300 attendees across science, biotech, pharma, and investment.
The focus is not on broad, high-level discussion. It is on what is actually working, what is still unclear, and what it takes to move aging biology into practice.
Find this year's agenda, speaker lineup, and pitch competition information
HERE
.
What Will Be Covered
Day 1: Science → Translation → Capital
Day 1 is grounded in the biology of aging and how it connects to real intervention and company formation.
Discussions will focus on:
Core mechanisms driving aging and age-related disease, including areas like mitochondrial dysfunction, immune aging, and epigenetic regulation
How these biological insights are being translated into therapeutics, biomarkers, and measurable interventions
The current state of aging clocks and other approaches to quantifying aging
What it actually takes to build in longevity, from early validation to infrastructure and execution
How investors and pharmaceutical companies are evaluating the space, including where there is real traction and where skepticism remains
The goal is to connect foundational science directly to how programs and companies are being built today.
Day 2: Clinical → Deployment → Scale
Day 2 shifts to how aging science is applied in real-world systems and where the field is heading next.
Discussions will focus on:
How aging biology is being integrated into clinical and patient-facing models
The role of longitudinal biomarker tracking and continuous lab testing in preventative care
How real-world data is beginning to inform intervention strategies and clinical trial design
The challenges and opportunities in scaling these models across broader populations
The role of AI and data infrastructure in both discovery and clinical deployment
Day 2 also features:
Live pitch competition finals for Seed and Series A companies building in aging and longevity -
APPLY TO PITCH HERE
Direct interaction between founders, investors, and pharma teams evaluating the space
Who This Is For
This is a space for people actively building in the field:
Scientists advancing aging biology and age-related disease research
Founders developing therapeutics, platforms, and diagnostics
Investors exploring where the field is heading
Pharma and BD teams evaluating new approaches
Operators working across data, infrastructure, and clinical systems
Physicians integrating aging biomarkers and preventative approaches into care
Science-driven wellness and nutrition practitioners
What This Becomes
Aging research is moving quickly, but real impact depends on how effectively those insights are applied in the real world.
Aging Code Summit brings together the people needed to turn that work into tangible outcomes.
Information Source: Longevity Global | eventbrite